To demonstrate that TINPAT induction upon DAC and HDACi treatment is not restricted to NCI-H1299 cells, we performed DNMT and HDAC inhibition in a large panel of cancer cell lines of several tissue types and cancer entities, including lung cancer, acute myeloid leukemia, glioblastoma, and colon cancer. This evidence concerns the gene DNMT1 and cancer.